Urien S - Search Results

1

Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice.

Bonhomme-Faivre L, Pelloquin A, Tardivel S, Urien S, Mathieu MC, Castagne V, Lacour B, Farinotti R. Bonhomme-Faivre L, et al. Among authors: urien s. Anticancer Drugs. 2002 Jan;13(1):51-7. doi: 10.1097/00001813-200201000-00006. Anticancer Drugs. 2002. PMID: 11914641

2

Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.

Castagne V, Bonhomme-Faivre L, Urien S, Ben Reguiga M, Soursac M, Gimenez F, Farinotti R. Castagne V, et al. Among authors: urien s. Drug Metab Dispos. 2004 Feb;32(2):168-71. doi: 10.1124/dmd.32.2.168. Drug Metab Dispos. 2004. PMID: 14744937

3

Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.

Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S. Antignac M, et al. Among authors: urien s. Eur J Clin Pharmacol. 2005 Jul;61(5-6):409-16. doi: 10.1007/s00228-005-0933-6. Epub 2005 Jul 1. Eur J Clin Pharmacol. 2005. PMID: 15991041

4

Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients.

Antignac M, Barrou B, Farinotti R, Lechat P, Urien S. Antignac M, et al. Among authors: urien s. Br J Clin Pharmacol. 2007 Dec;64(6):750-7. doi: 10.1111/j.1365-2125.2007.02895.x. Epub 2007 Apr 10. Br J Clin Pharmacol. 2007. PMID: 17425625 Free PMC article.

5

Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.

Antignac M, Fernandez C, Barrou B, Roca M, Favrat JL, Urien S, Farinotti R. Antignac M, et al. Among authors: urien s. Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):25-33. doi: 10.1007/s13318-011-0027-z. Epub 2011 Feb 24. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21347736

6

Population pharmacokinetics of everolimus in cardiac recipients: comedications, ABCB1, and CYP3A5 polymorphisms.

Lemaitre F, Bezian E, Goldwirt L, Fernandez C, Farinotti R, Varnous S, Urien S, Antignac M. Lemaitre F, et al. Among authors: urien s. Ther Drug Monit. 2012 Dec;34(6):686-94. doi: 10.1097/FTD.0b013e318273c899. Ther Drug Monit. 2012. PMID: 23131698

7

Weekly administration of paclitaxel: theoretical and clinical basis.

Marchetti P, Urien S, Cappellini GA, Ronzino G, Ficorella C. Marchetti P, et al. Among authors: urien s. Crit Rev Oncol Hematol. 2002 Dec 27;44 Suppl:S3-13. doi: 10.1016/s1040-8428(02)00109-9. Crit Rev Oncol Hematol. 2002. PMID: 12505595 Review.

8

Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.

Urien S, Doz F, Giraud C, Rey E, Gentet JC, Chastagner P, Vassal G, Corradini N, Auvrignon A, Leblond P, Rubie H, Treluyer JM. Urien S, et al. Cancer Chemother Pharmacol. 2011 Mar;67(3):597-603. doi: 10.1007/s00280-010-1357-2. Epub 2010 May 20. Cancer Chemother Pharmacol. 2011. PMID: 20490798 Clinical Trial.

9

Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment.

Hulot JS, Vantelon C, Urien S, Bouzamondo A, Mahé I, Ankri A, Montalescot G, Lechat P. Hulot JS, et al. Among authors: urien s. Ther Drug Monit. 2004 Jun;26(3):305-10. doi: 10.1097/00007691-200406000-00015. Ther Drug Monit. 2004. PMID: 15167633 Clinical Trial.

10

Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria.

Simon N, Morin C, Urien S, Tillement JP, Bruguerolle B. Simon N, et al. Among authors: urien s. Br J Pharmacol. 2003 Jan;138(2):369-76. doi: 10.1038/sj.bjp.0705038. Br J Pharmacol. 2003. PMID: 12540528 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters